OneMedNet Corp

ONMD

OneMedNet Corp

ONMD

Insider Sentiment (TTM):

Last Purchase:2026-06-23Last Sale:2025-11-18Shares Purchased (TTM):2,038,874Shares Sold (TTM):61,555

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:10,718,313Shares Outstanding:55,316,371Institutional Ownership Pct.:19.38%

Earnings Market Reaction:

Filing Date:2026-08-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash	-	-	-	-	-	-	-	-	-	-	-	0
Prepaid Expense Current	-	-	-	-	-	-	-	-	-	-	-	0
Cash And Cash Equivalents At Carrying Value	0	0	1	0	0	0	0	2	0	0	0	1
Restricted Cash Current	-	-	-	-	-	-	-	-	0	-	-	-
Crypto Asset Fair Value	-	0	1	1	2	1	3	2	-	-	-	-
Accounts Receivable Net Current	1	1	0	1	0	0	0	0	0	0	0	0
Prepaid Expense And Other Assets Current	0	0	1	0	0	0	0	0	0	0	0	0
Other Receivables Net Current	-	-	-	-	-	-	-	-	-	-	-	2
Assets Current	1	1	2	1	2	2	4	4	1	1	0	0
Assets Held In Trust Noncurrent	-	-	-	-	-	-	-	-	-	-	-	19
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Assets	1	2	2	2	2	2	4	4	1	1	0	19
Accrued Liabilities Current	-	-	-	-	-	-	-	-	-	-	-	3
Liabilities And Stockhold…
Other Short Term Borrowings	-	-	-	-	-	-	-	-	-	-	0	-
Liabilities Current
Accounts Payable And Accrued Liabilities Current	3	4	3	4	5	7	6	6	6	6	5	1
Deferred Revenue Current	1	1	0	1	1	1	1	0	1	0	0	0
Convertible Debt Current	-	-	-	-	-	-	-	-	-	-	-	12
Other Notes Payable Current	-	-	-	-	-	-	-	-	2	2	2	-
Line Of Credit	-	-	-	-	-	-	-	-	1	0	-	-
Loans Payable Current	1	1	1	0	0	3	4	3	-	-	3	-
Sales And Excise Tax Payable Current	-	-	-	-	-	-	-	-	-	-	0	0
Notes Payable Current	-	-	-	-	-	2	2	2	-	-	2	-
Convertible Notes Payable Current	-	-	-	-	-	-	3	-	-	-	-	-
Short Term Borrowings	-	-	-	-	-	2	2	2	-	-	0	-
Loans Payable	-	-	-	-	-	-	-	-	-	-	0	-
Unsecured Debt Current	-	-	-	-	-	-	-	-	-	-	0	0
Accrued Income Taxes Current	-	-	-	-	-	-	-	-	-	-	0	0
Liabilities Current	5	5	5	5	6	18	19	19	20	15	13	3
Other Liabilities Current	-	-	-	-	-	-	0	-	-	-	0	-
Other Liabilities Noncurrent	-	-	-	0	0	0	0	0	0	0	0	-
Long Term Loans Payable	0	0	0	-	-	-	-	-	-	-	0	4
Liabilities	5	6	5	5	6	18	20	19	20	16	14	12
Temporary Equity Carrying Amount Attributable To P…	-	-	-	-	-	-	-	-	-	-	-	19
Temporary Equity
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Noncurrent
Convertible Debt Noncurrent	-	-	-	-	-	-	-	-	-	-	-	2
Additional Paid In Capital	106	103	102	98	97	87	86	85	78	78	78	1
Treasury Stock Common Value	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1	-	-
Retained Earnings Accumulated Deficit	-109	-107	-104	-101	-100	-103	-102	-99	-97	-94	-91	-13
Stockholders Equity	-4	-4	-3	-4	-4	-17	-16	-14	-19	-16	-13	-12
Liabilities And Stockholders Equity	-	-	2	2	2	2	4	4	1	1	0	19
Temporary Equity Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	2
Temporary Equity Redemption Price Per Share	-	-	-	-	-	-	-	-	-	-	-	11.22
Allowance For Doubtful Accounts Receivable Current	-	-	-	-	-	-	-	-	-	-	0	0
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	1	1	1	1	1	1	1	1	1	1	1	1
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0.36	0	0	0	0	0	0	0
Common Stock Shares Authorized	100	100	100	100	100	100	100	100	100	100	100	30
Common Stock Shares Issued	58	53	52	50	46	31	28	28	24	24	24	5
Shares Outstanding	58	53	52	50	46	31	28	28	24	24	24	5
Treasury Stock Common Shares	0	0	0	0	0	0	0	0	0	0	0	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-19.50%	-20.45%	-14.39%	-	-	-	-	-	-	-	-	-
2025	-17.31%	17.74%	2.99%	81.04%	114.58%	341.67%	26.43%	-12.86%	-45.43%	38.54%	13.73%	-29.60%
2024	25.47%	27.36%	-6.60%	57.43%	14.19%	-0.22%	20.17%	4.08%	-19.42%	-23.08%	-27.39%	3.38%
2023	-	-	-	-	-	-	-80.59%	-83.97%	-76.79%	-15.63%	240.85%	38.45%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	0.28	0.27	0.43	0.29	0.37	0.09	0.19	0.23	0.05	0.04	0.03	0.01
Quick Ratio	0.22	0.19	0.33	0.27	0.32	0.07	0.17	0.22	0.04	0.03	0.01	0.00
Working Capital	-3.41M	-3.90M	-2.73M	-3.56M	-3.89M	-16.52M	-15.61M	-14.32M	-19.09M	-14.00M	-13.01M	-3.06M
Leverage & Debt
Debt to Equity	-1.39	-1.37	-1.73	-1.38	-1.61	-1.10	-1.23	-1.31	-1.05	-1.05	-1.03	-1.01
Interest Coverage TTM	-308.88	-217.28	-144.28	-106.16	-79.80	-71.53	-65.34	-16.01	-7.76	-7.22	-6.89	-15.38
Debt Ratio	3.58	3.71	2.38	3.62	2.64	10.56	5.28	4.25	19.43	21.93	29.97	0.61
Efficiency & Turnover
Asset Turnover TTM	0.79	0.81	0.46	0.17	0.27	0.43	0.31	0.08	0.07	0.07	1.16	0.01
Days Sales Outstanding TTM	115.14	130.71	95.08	237.80	130.53	171.52	103.60	29.04	24.38	86.38	30.57	32.74
Receivables Turnover TTM	3.17	2.79	3.84	1.53	2.80	2.13	3.52	12.57	14.97	4.23	11.94	11.15
Per Share Metrics
Diluted EPS TTM	-0.15	-0.06	-0.06	-0.04	-0.09	-0.29	-0.36	-0.80	-0.88	-1.13	-3.68	-20.28
Free Cash Flow Per Share TTM	-0.12	-0.13	-0.17	-0.11	-0.17	-0.21	-0.25	-0.31	-0.24	-0.22	-0.68	-2.19
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-67.56%	-50.00%	-37.01%	-144.04%	-125.00%	-81.95%	-43.70%	-28.86%	-13.71%	-10.20%	-12.63%	-26.55%
Operating Profit Margin TTM	-700.55%	-758.35%	-711.33%	-1,865.86%	-2,029.78%	-1,828.57%	-1,493.78%	-1,042.12%	-745.15%	-700.19%	-671.20%	-1,012.30%
Net Profit Margin TTM	-584.60%	-254.32%	-206.11%	-410.91%	-728.48%	-1,865.04%	-1,575.27%	-2,480.56%	-1,963.58%	-2,625.16%	-2,550.44%	-4,563.38%
Growth Metrics
Net Revenue Growth (1Y)	216.30%	147.74%	111.35%	-47.28%	-59.04%	-50.23%	-37.02%	-2.50%	-26.41%	-20.99%	-11.45%	8.33%
Net Income Growth (1Y)	153.83%	-66.22%	-72.35%	-91.27%	-84.80%	-64.64%	-61.10%	-47.00%	-49.05%	-14.27%	-14.49%	-1,838.61%
EPS Growth (1Y)	61.16%	-79.17%	-82.57%	-95.14%	-89.61%	-74.16%	-90.19%	-96.08%	-91.84%	-86.13%	-52.03%	-9,327.66%
Valuation Metrics
P/E TTM	-4.85	-14.03	-17.49	-28.20	-6.27	-1.86	-3.77	-0.77	-1.12	-0.63	-0.22	-0.56
P/B TTM	-11.73	-11.53	-16.53	-14.56	-5.47	-1.11	-2.39	-1.25	-1.29	-1.13	-0.43	-2.10
P/S TTM	28.35	35.67	36.06	115.87	45.64	34.62	59.38	19.04	22.04	16.55	5.62	25.33
Market Cap	41.25M	47.02M	49.00M	57.35M	21.00M	18.42M	38.18M	17.88M	24.75M	17.69M	5.74M	24.40M
Enterprise Value	41.46M	47.45M	49.17M	57.59M	21.27M	25.20M	49.13M	22.84M	24.35M	17.52M	10.83M	38.31M
Calculated Values
Free Cash Flow TTM	-7.21M	-7.21M	-7.52M	-5.97M	-6.14M	-7.31M	-7.00M	-8.98M	-5.92M	-5.39M	-4.84M	-4.74M
Net Debt	211.00K	428.00K	169.00K	239.00K	278.00K	6.78M	10.94M	4.96M	-407.00K	-174.00K	5.09M	13.91M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-23Purchase

Owner: Green, Aaron

Title: Chief Executive Officer

Shares: 36,650

Price/Share: $0.57

Value: $20,890.50

Shares Owned: 1,896,375

Relationship: Director,Officer

Ownership: Direct

2026-06-23Purchase

Owner: Yu, Jeffrey

Title: Chief Medical Officer

Shares: 158,730

Price/Share: $0.63

Value: $99,999.90

Shares Owned: 8,780,410

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2026-06-16Purchase

Owner: Yu, Jeffrey

Title: Chief Medical Officer

Shares: 172,414

Price/Share: $0.58

Value: $100,000.12

Shares Owned: 8,621,680

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2026-06-15Purchase

Owner: Green, Aaron

Title: Chief Executive Officer

Shares: 18,702

Price/Share: $0.54

Value: $10,099.08

Shares Owned: 1,859,725

Relationship: Director,Officer

Ownership: Direct

2026-06-12Purchase

Owner: Kosasa, Thomas

Title: -

Shares: 158,730

Price/Share: $0.63

Value: $99,999.90

Shares Owned: 17,088,874

Relationship: Director,TenPercentOwner

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-23	Green, Aaron	Director,Officer	Chief Executive Officer	Direct	Purchase	36,650	0.57	$20,890.50	1,896,375	4
2026-06-23	Yu, Jeffrey	Director,Officer,TenPercentOwner	Chief Medical Officer	Direct	Purchase	158,730	0.63	$99,999.90	8,780,410	4
2026-06-16	Yu, Jeffrey	Director,Officer,TenPercentOwner	Chief Medical Officer	Direct	Purchase	172,414	0.58	$100,000.12	8,621,680	4
2026-06-15	Green, Aaron	Director,Officer	Chief Executive Officer	Direct	Purchase	18,702	0.54	$10,099.08	1,859,725	4
2026-06-12	Kosasa, Thomas	Director,TenPercentOwner	-	Direct	Purchase	158,730	0.63	$99,999.90	17,088,874	4
2026-05-18	Kosasa, Thomas	Director,TenPercentOwner	-	Direct	Purchase	268,817	0.93	$249,999.81	16,930,144	4
2026-04-23	Kosasa, Thomas	Director,TenPercentOwner	-	Direct	Purchase	280,898	0.89	$249,999.22	16,661,327	4
2026-04-01	Yu, Jeffrey	Director,Officer,TenPercentOwner	Chief Medical Officer	Direct	Purchase	903,614	0.83	$749,999.62	8,229,837	4
2025-11-18	Green, Aaron	Director,Officer	Chief Executive Officer	Direct	Sale	61,555	1.20	$73,866.00	1,804,103	4
2025-10-15	Casaburi, Eric	Director	-	Direct	Purchase	10,000	3.05	$30,500.00	65,475	4
2025-09-24	Kosasa, Thomas	Director	-	Direct	Purchase	6,000	0.93	$5,580.00	15,740,191	4
2025-09-02	Yu, Jeffrey	Director,Officer	Chief Medical Officer	Direct	Purchase	24,319	0.85	$20,671.15	7,029,143	4
2024-12-18	Yu, Jeffrey	Director,Officer	Chief Medical Officer	Direct	Purchase	100	0.99	$99.00	2,763,195	4
2024-01-30	Yu, Jeffrey	Director,Officer	Chief Medical Officer	Direct	Purchase	400	1.14	$456.00	2,522,886	4
2023-12-07	Golden, Robert Lawrence	Director,Officer	Chief Financial Officer	Direct	Purchase	300	1.71	$513.00	300	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

19.38%

Inst. Shares: 10,718,313

Shares Outstanding: 55,316,371

2025-12-31

13.19%

Inst. Shares: 5,875,499

Shares Outstanding: 44,547,815

2025-09-30

22.78%

Inst. Shares: 11,987,974

Shares Outstanding: 52,618,031

2025-06-30

13.24%

Inst. Shares: 4,876,419

Shares Outstanding: 36,835,945

2025-03-31

14.18%

Inst. Shares: 4,834,250

Shares Outstanding: 34,103,724

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	10,718,313	55,316,371	19.38%
2025-12-31	5,875,499	44,547,815	13.19%
2025-09-30	11,987,974	52,618,031	22.78%
2025-06-30	4,876,419	36,835,945	13.24%
2025-03-31	4,834,250	34,103,724	14.18%
2024-12-31	4,151,653	28,076,512	14.79%
2024-09-30	5,913,163	29,265,023	20.21%
2024-06-30	3,630,805	25,180,764	14.42%
2024-03-31	1,062,478	24,922,490	4.26%
2023-12-31	306,885	7,084,068	4.33%
2023-09-30	1,498,211	2,166,749	69.15%
2023-06-30	2,085,969	4,033,170	51.72%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

OneMedNet Corp (ONMD) — SEC Financial Statements & Analysis

OneMedNet Corp (ONMD) is a services-commercial physical & biological research company, incorporated in DE. OneMedNet Corp trades on Nasdaq as: ONMD, ONMDW. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), OneMedNet Corp reported a 216.30% year-over-year revenue growth, a Gross Profit Margin of -67.56% (TTM), a Debt-to-Equity ratio of -1.39x, a Price-to-Sales (P/S) ratio of 28.35x (TTM), a Price-to-Book (P/B) ratio of -11.73x (TTM), at a market cap of $41.25M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 216.30%
Gross Profit Margin TTM: -67.56%
Debt To Equity: -1.39x
P/S TTM: 28.35x
P/B TTM: -11.73x
Market Cap: $41.25M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is OneMedNet Corp in?

OneMedNet Corp (ONMD) operates in the Services-Commercial Physical & Biological Research industry.

What is ONMD's market cap?

OneMedNet Corp (ONMD) has a market capitalization of $41.25M as of 2026-06-30.

What exchange does ONMD trade on?

OneMedNet Corp (ONMD) trades on the Nasdaq.

Where is OneMedNet Corp incorporated?

OneMedNet Corp is incorporated in DE.

OneMedNet Corp

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

OneMedNet Corp (ONMD) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Services-Commercial Physical & Biological Research

Wall Street's data.
Main Street's price.

OneMedNet Corp (ONMD) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Services-Commercial Physical & Biological Research

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.